The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and Langendorff-perfused hearts

被引:56
作者
Aplin, Mark
Christensen, Gitte Lund
Schneider, Mikael
Heydorn, Arne
Gammeltoft, Steen
Kjolbye, Anne Louise
Sheikh, Soren P.
Hansen, Jakob Lerche
机构
[1] Univ Copenhagen Hosp, Mol Cardiol Lab, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, DK-2100 Copenhagen, Denmark
[2] Univ Copenhagen Hosp, Ctr Heart, DK-2100 Copenhagen, Denmark
[3] Glostrup Cty Hosp, Dept Clin Biochem, DK-2600 Glostrup, Denmark
[4] BioImage AS, Soborg, Denmark
[5] Zealand Pharma AS, Glostrup, Denmark
[6] Odense Univ Hosp, Dept Biochem Pharmacol & Genet, DK-5000 Odense, Denmark
关键词
D O I
10.1111/j.1742-7843.2007.00063.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The angiotensin II (AngII) type I receptor (AT(1)R) has been shown to activate extracellular signal -regulated kinases 1 and 2 (ERK1/2) through G proteins or G protein-independently through beta-arrestin2 in cellular expression systems. As activation mechanisms may greatly influence the biological effects of ERK1/2 activity, differential activation of the AT(1)R in its native cellular context could have important biological and pharmacological implications. To examine if AT(1)R activates ERK1/2 by G protein-independent mechanisms in the heart, We used the [Sar(1), Ile(4), Ile(8)]-AngII ([SII] AngII) analogue in native preparations of cardiac myocytes and beating hearts. We found that [SII] AngII does not activate G(q)-coupling, yet stimulates the beta-arrestin2-dependent ERK1/2. The G(q)-activated pool of ERK1/2 rapidly translocates to the nucleus, while the beta-arrestin2-scaffolded pool remains in the cytosol. Similar biased agonism was achieved in Langendorff-perfused hearts, where both agonists elicit ERK1/2 phosphorylation, but [SII] AngII induces neither inotropic nor chronotropic effects.
引用
收藏
页码:289 / 295
页数:7
相关论文
共 34 条
[1]   Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by β-arrestins 1 and 2 [J].
Ahn, S ;
Wei, HJ ;
Garrison, TR ;
Lefkowitz, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (09) :7807-7811
[2]   Differential kinetic and spatial patterns of β-arrestin and G protein-mediated ERK activation by the angiotensin II receptor [J].
Ahn, SK ;
Shenoy, SK ;
Wei, HJ ;
Lefkowitz, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (34) :35518-35525
[3]   Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytes [J].
Aplin, Mark ;
Christensen, Gitte Lund ;
Schneider, Mikael ;
Heydorn, Arne ;
Gammeltoft, Steen ;
Kjolbye, Anne Louise ;
Sheikh, Soren P. ;
Hansen, Jakob Lerche .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 100 (05) :296-301
[4]   Identification of ischemia-regulated phosphorylation sites in connexin43: A possible target for the antiarrhythmic peptide analogue rotigaptide (ZP123) [J].
Axelsen, Lene N. ;
Stahlhut, Martin ;
Mohammed, Shabaz ;
Larsen, Bjarne Due ;
Nielsen, Morten S. ;
Holstein-Rathlou, Niels-Henrik ;
Andersen, Soren ;
Jensen, Ole N. ;
Hennan, James K. ;
Kjolbye, Anne Louise .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 40 (06) :790-798
[5]   Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy [J].
Busk, PK ;
Hinrichsen, R ;
Bartkova, J ;
Hansen, AH ;
Christoffersen, TEH ;
Bartek, H ;
Haunso, S .
EXPERIMENTAL CELL RESEARCH, 2005, 304 (01) :149-161
[6]   Arrestin-mediated ERK activation by gonadotropin-releasing hormone receptors - Receptor-specific activation mechanisms and compartmentalization [J].
Caunt, CJ ;
Finch, AR ;
Sedgley, KR ;
Oakley, L ;
Luttrell, LM ;
McArdle, CA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (05) :2701-2710
[7]   The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling [J].
Charest, Pascale G. ;
Oligny-Longpre, Genevieve ;
Bonin, Helene ;
Azzi, Mounia ;
Bouvier, Michel .
CELLULAR SIGNALLING, 2007, 19 (01) :32-41
[8]   Oligomerization of wild type and nonfunctional mutant angiotensin II type I receptors inhibits Gαq protein signaling but not ERK activation [J].
Hansen, JL ;
Theilade, J ;
Haunso, S ;
Sheikh, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (23) :24108-24115
[9]   Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers - A meta-analysis [J].
Healey, JS ;
Baranchuk, A ;
Crystal, E ;
Morillo, CA ;
Garfinkle, M ;
Yusuf, S ;
Connolly, SJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (11) :1832-1839
[10]   Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors [J].
Holloway, AC ;
Qian, HW ;
Pipolo, L ;
Ziogas, J ;
Miura, SI ;
Karnik, S ;
Southwell, BR ;
Lew, MJ ;
Thomas, WG .
MOLECULAR PHARMACOLOGY, 2002, 61 (04) :768-777